Home › Pulmonary Arterial Hypertension › Arizona
Pulmonary Arterial Hypertension clinical trials in Arizona
6 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Arizona.
Cities in Arizona
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- Arizona Pulmonary Specialists ( Site 1010), Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07218029An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Arizona Pulmonary Specialists, LTD, Scottsdale
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07365332A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Arizona Pulmonary Specialists, Phoenix
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Arizona Pulmonary Specialists Ltd, Scottsdale
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- Arizona Pulmonary Specialists, Ltd., Phoenix
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
- University of Arizona, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 20, 2025 · NCT04062565From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.